| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Lyons Gary A is a Director at NEUROCRINE BIOSCIENCES INC with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $25.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $84.67 | $423,341.00 | -1.9% | |
| Feb 5, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $83.08 | $415,380.00 | -1.8% | |
| Dec 1, 2017 | NBIX Neurocrine Biosciences Inc | Director | Sell | 10,000 | $72.92 | $729,182.00 | -3.5% |